Community Research and Development Information Service - CORDIS

Establishing innovative drug discovery expertise in the Baltics [Print to PDF] [Print to RTF]

An EU-funded project designed to strengthen multidisciplinary research capacities, and to better manage intellectual property issues surrounding innovative drug discovery, has been launched. The opening ceremony took place at the Latvian Institute of Organic Synthesis (LIOS), ...
Establishing innovative drug discovery expertise in the Baltics
An EU-funded project designed to strengthen multidisciplinary research capacities, and to better manage intellectual property issues surrounding innovative drug discovery, has been launched. The opening ceremony took place at the Latvian Institute of Organic Synthesis (LIOS), where the project's aims and objectives were outlined.

InnovaBalt aims to encourage the integration of LIOS into the European Research area, and in doing so help tackle some major challenges in the European health sector. The LIOS is a leading regional research centre dedicated to drug discovery, but requires expertise in a number of disciplines - organic synthesis, medicinal chemistry and the pharmaceutical development of compounds designed for numerous disorders - in order to be globally competitive.

All this of course requires investment, training and on-going collaboration, which is what InnovaBalt aims to address. In particular, this project aims to strengthen the management of intellectual property (IP) and human resources for innovative drug discovery at LIOS, in order to ensure that the centre has a strong and secure future. One way this will be achieved is through attracting 14 external professionals with experience in this field.

Another key InnovaBalt objective is to develop the institute's research activities in innovative medicine in other ways. These include establishing long-lasting scientific collaboration and strategic partnerships with 50 outstanding research institutions, which will help to increase the visibility of LIOS within the European Research Area (ERA). This will improve the institute's participation in FP Horizon 2020 and other European research programmes' activities.

Research infrastructure and qualifications at LIOS will be upgraded in the fields of modern process chemistry, green chemistry, biophysical chemistry, drug discovery, advanced forms for drug delivery and research and innovation management, in order to promote the capacity for high-level research on innovative drug development.

There will be planned trainings on Horizon 2020 and Intellectual property management issues, which will increase the institute's competitiveness. Increased activity of LIOS in European projects, networks and other activities will also ensure that the centre is able to more fully fulfil its potential. In this way, the project will not only unlock the existing research and innovation capacities of LIOS; it will contribute to research and innovation capacity building in the Baltic region. With a contribution of EUR 4.7 million from the Commission, this is the largest FP7 project implemented in Latvia so far.
Source: LIOS

Related information

Record Number: 36152 / Last updated on: 2013-10-11
Category: Project
Provider: EC